Cybin Revenue

Revenue

n/a

Revenue Growth

n/a

P/S Ratio

n/a

Revenue / Employee

n/a

Employees

Market Cap

195.00M

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2024	-	-	-
Mar 31, 2023	-	-	-
Mar 31, 2022	-	-	-
Mar 31, 2021	864.00K	-	-
Mar 31, 2020	-	-	-

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Green Thumb Industries	1.64B
dentalcorp Holdings	1.58B
Sienna Senior Living	896.45M
Extendicare	1.47B
Trulieve Cannabis	1.71B
Cronos Group	179.08M
WELL Health Technologies	919.69M
Curaleaf Holdings	1.89B

Revenue Rankings

Cybin News

5 days ago - Cybin Announces Additional U.S. Patent Supporting its CYB003 Breakthrough Therapy Program in Phase 3 Development for Major Depressive Disorder - Business Wire
12 days ago - Cybin to Participate at the 28th Annual Milken Institute Global Conference - Business Wire
20 days ago - Cybin Announces Additional Strategic Clinical Site Partnerships to Support PARADIGM, a Multinational Phase 3 Program Evaluating CYB003 - Business Wire
22 days ago - Psychedelic drug developer Cybin partners with Osmind - Seeking Alpha
22 days ago - Cybin Partners with Osmind to Accelerate Commercial Preparation for its Clinical-Stage Psychiatry Programs - Business Wire
2 months ago - Cybin wins new Buy from Guggenheim: potential to challenge J&J’s Spravato cited - Seeking Alpha
3 months ago - Cybin reports Q3 results - Seeking Alpha
3 months ago - Cybin Reports Third Quarter Fiscal Year 2025 Financial Results and Recent Business Highlights - Business Wire

More News